Farha Khan, MD
Endocrinology, Diabetes & Metabolism · Coon Rapids, MNNPI 1730121765
Payments from drug & device makers
Across 537 payments — averaging $649.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$141K
- Lilly USA, LLC$82K
- AstraZeneca$45K
- Dexcom, Inc.$35K
- Abbott$28K
- Insulet Corporation$16K
- plus $3K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 160 | $140,691 |
| Lilly USA, LLC | 171 | $81,887 |
| AstraZeneca(2 entities) | 53 | $44,661 |
| Dexcom, Inc. | 40 | $34,644 |
| Abbott | 35 | $27,657 |
| Insulet Corporation | 27 | $16,474 |
| Corcept Therapeutics | 1 | $1,400 |
| E.r. Squibb & Sons, L.L.C. | 1 | $297 |
| Medtronic(2 entities) | 5 | $102 |
| Ascensia Diabetes Care US Inc. | 5 | $88 |
| Bayer | 5 | $86 |
| BETA Bionics, Inc. | 5 | $82 |
| Sanofi-aventis U.S. LLC | 4 | $69 |
| Radius Health, Inc. | 4 | $52 |
| Ultragenyx Pharmaceutical Inc. | 3 | $46 |
| Recordati_rare_diseases_inc. | 3 | $42 |
| Tandem Diabetes Care, Inc. | 2 | $38 |
| Companion Medical, Inc. | 2 | $24 |
| Valeritas, Inc. | 1 | $24 |
| Amgen | 2 | $24 |
| Kyowa Kirin, Inc. | 1 | $22 |
| Shire North American Group Inc | 1 | $22 |
| Ipsen Biopharmaceuticals, Inc | 1 | $19 |
| Ionis Pharmaceuticals, Inc. | 1 | $18 |
| Sequel Med Tech, LLC | 1 | $17 |
| Rhythm Pharmaceuticals, Inc. | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
| Cequr Corporation | 1 | $13 |
How this compares
$348,529 in reported general payments places this provider in the 90th percentile of 120 endocrinology, diabetes & metabolism providers in Minnesota.
See all endocrinology, diabetes & metabolism providers in Minnesota →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Coon Rapids
- Kathryn O'DayCoon Rapids$1K
- Anders CarlsonSt Louis Park$5.6M
- Irina BancosRochester$4.8M
- Richard BergenstalSt Louis Park$4M
- Yogish KudvaRochester$2.9M
- Marius StanRochester$2.2M
- John MorrisRochester$1.9M
- Adrian VellaRochester$1.7M
- Haleigh JamesSt Louis Park$1.1M
- Mabel RyderRochester$691K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.